Literature DB >> 23824808

Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.

Qing Li1, Jianxun Qi, Yan Wu, Hiromasa Kiyota, Kosuke Tanaka, Yoshitomo Suhara, Hiroshi Ohrui, Yasuo Suzuki, Christopher J Vavricka, George F Gao.   

Abstract

The influenza virus neuraminidase H274Y substitution is a highly prevalent amino acid substitution associated with resistance to the most heavily used influenza drug, oseltamivir. Previous structural studies suggest that the group specific 252 residue (Y252 in group 1 and T252 in group 2) might be a key factor underlying H274Y resistance. However, H274Y has only been reported in N1 subtypes, which indicates that there must be additional key residues that determine H274Y resistance. Furthermore, we found that members of NA serotype N3 also possess Y252, raising the key question as to whether or not H274Y resistance may also be possible for some group 2 NAs. Here, we demonstrate that the H274Y substitution results in mild oseltamivir resistance for N3. Comparative structural analysis of N3, N1, and their 274Y variants indicates that the interaction of residue 296 (H in N1 and nonaromatic for other serotypes) with conserved W295 is another important determinant of oseltamivir resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824808      PMCID: PMC3753999          DOI: 10.1128/JVI.01129-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Structural and kinetic analysis of two covalent sialosyl-enzyme intermediates on Trypanosoma rangeli sialidase.

Authors:  Andrew G Watts; Pablo Oppezzo; Stephen G Withers; Pedro M Alzari; Alejandro Buschiazzo
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

2.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

Review 3.  Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.

Authors:  Robert W Sidwell; Donald F Smee
Journal:  Expert Opin Investig Drugs       Date:  2002-06       Impact factor: 6.206

4.  Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.

Authors:  Xueyong Zhu; Hua Yang; Zhu Guo; Wenli Yu; Paul J Carney; Yan Li; Li-Mei Chen; James C Paulson; Ruben O Donis; Suxiang Tong; James Stevens; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site.

Authors:  Qing Li; Jianxun Qi; Wei Zhang; Christopher J Vavricka; Yi Shi; Jinhua Wei; Enguang Feng; Jingshan Shen; Jilong Chen; Di Liu; Jianhua He; Jinghua Yan; Hong Liu; Hualiang Jiang; Maikun Teng; Xuebing Li; George F Gao
Journal:  Nat Struct Mol Biol       Date:  2010-09-19       Impact factor: 15.369

6.  CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.

Authors:  Makoto Yamashita; Takanori Tomozawa; Masayo Kakuta; Akane Tokumitsu; Hatsumi Nasu; Shuku Kubo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

7.  Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.

Authors:  Christopher J Vavricka; Yue Liu; Hiromasa Kiyota; Nongluk Sriwilaijaroen; Jianxun Qi; Kosuke Tanaka; Yan Wu; Qing Li; Yan Li; Jinghua Yan; Yasuo Suzuki; George F Gao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Authors:  Darwyn Kobasa; Ayato Takada; Kyoko Shinya; Masato Hatta; Peter Halfmann; Steven Theriault; Hiroshi Suzuki; Hidekazu Nishimura; Keiko Mitamura; Norio Sugaya; Taichi Usui; Takeomi Murata; Yasuko Maeda; Shinji Watanabe; M Suresh; Takashi Suzuki; Yasuo Suzuki; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2004-10-07       Impact factor: 49.962

9.  Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase.

Authors:  J N Varghese; P W Smith; S L Sollis; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin; P M Colman
Journal:  Structure       Date:  1998-06-15       Impact factor: 5.006

10.  Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.

Authors:  Christopher J Vavricka; Qing Li; Yan Wu; Jianxun Qi; Mingyang Wang; Yue Liu; Feng Gao; Jun Liu; Enguang Feng; Jianhua He; Jinfang Wang; Hong Liu; Hualiang Jiang; George F Gao
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

View more
  14 in total

Review 1.  Single enzyme nanoparticle, an effective tool for enzyme replacement therapy.

Authors:  Dong Hyun Kim; Han Sol Lee; Tae-Wan Kwon; Young-Min Han; Nae-Won Kang; Mee Yeon Lee; Dae-Duk Kim; Myeong Gyu Kim; Jae-Young Lee
Journal:  Arch Pharm Res       Date:  2020-01-27       Impact factor: 4.946

2.  Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses.

Authors:  Hua Yang; Paul J Carney; Vasiliy P Mishin; Zhu Guo; Jessie C Chang; David E Wentworth; Larisa V Gubareva; James Stevens
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

3.  Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.

Authors:  Meiling Dai; Hongbo Guo; Jos C F M Dortmans; Jojanneke Dekkers; Johan Nordholm; Robert Daniels; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

4.  The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Authors:  Nalini Schaduangrat; Jiraphorn Phanich; Thanyada Rungrotmongkol; Hatairat Lerdsamran; Pilaipan Puthavathana; Sukathida Ubol
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

5.  Predicting Displaceable Water Sites Using Mixed-Solvent Molecular Dynamics.

Authors:  Sarah E Graham; Richard D Smith; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2018-01-16       Impact factor: 4.956

6.  Synthesis and Neuraminidase Inhibitory Activity of Sialic Acid Analogues with Fluoro, Phosphono, and Sulfo Functionalities.

Authors:  Christopher J Vavricka; Nongluk Sriwilaijaroen; Yasuo Suzuki; Hiromasa Kiyota
Journal:  Methods Mol Biol       Date:  2022

7.  Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.

Authors:  Linghui Li; Yan Chai; Weiyu Peng; Delin Li; Litao Sun; George Fu Gao; Jianxun Qi; Haixia Xiao; William Jun Liu; Mark von Itzstein; Feng Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

8.  Structure of influenza virus N7: the last piece of the neuraminidase "jigsaw" puzzle.

Authors:  Xiaoman Sun; Qing Li; Yan Wu; Mingyang Wang; Yue Liu; Jianxun Qi; Christopher J Vavricka; George F Gao
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 9.  Drug resistance in influenza A virus: the epidemiology and management.

Authors:  Mazhar Hussain; Henry D Galvin; Tatt Y Haw; Ashley N Nutsford; Matloob Husain
Journal:  Infect Drug Resist       Date:  2017-04-20       Impact factor: 4.003

Review 10.  Bat-derived influenza-like viruses H17N10 and H18N11.

Authors:  Ying Wu; Yan Wu; Boris Tefsen; Yi Shi; George F Gao
Journal:  Trends Microbiol       Date:  2014-02-26       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.